235 related articles for article (PubMed ID: 33272734)
1. Silencing HIF-1α aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-α/ANGPTL4 singling pathway.
He Y; Yang W; Gan L; Liu S; Ni Q; Bi Y; Han T; Liu Q; Chen H; Hu Y; Long Y; Yang L
Gastroenterol Hepatol; 2021 May; 44(5):355-365. PubMed ID: 33272734
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway.
Chen J; Chen J; Fu H; Li Y; Wang L; Luo S; Lu H
Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E710-E722. PubMed ID: 31430204
[TBL] [Abstract][Full Text] [Related]
3. HIF-1-dependent lipin1 induction prevents excessive lipid accumulation in choline-deficient diet-induced fatty liver.
Arai T; Tanaka M; Goda N
Sci Rep; 2018 Sep; 8(1):14230. PubMed ID: 30242180
[TBL] [Abstract][Full Text] [Related]
4. [Effect of diosgenin on mTOR/FASN/HIF-1α/VEGFA expression in rats with non-alcoholic fatty liver disease].
Yin GL; Liang HY; Liang PP; Feng YN; Chen SW; Liu XY; Pan WC; Zhang FX
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1760-1769. PubMed ID: 37282950
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 protects against liver damage exacerbated by acetaminophen in non-alcoholic fatty liver disease by inhibiting the ERK/HIF-1α pathway.
You T; Li Y; Li B; Wu S; Jiang X; Fu D; Xin J; Huang Y; Jin L; Hu C
Mol Immunol; 2023 Nov; 163():104-115. PubMed ID: 37769575
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate alleviates NAFLD by enhancing the PPARα/PGC-1α signaling pathway coupling mitochondrial function.
Wang X; Wang J; Ying C; Xing Y; Su X; Men K
BMC Pharmacol Toxicol; 2024 Jan; 25(1):7. PubMed ID: 38173037
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of miR-181a impairs lipid metabolism by targeting PPARα expression in nonalcoholic fatty liver disease.
Huang R; Duan X; Liu X; Cao H; Wang Y; Fan J; Wang B
Biochem Biophys Res Commun; 2019 Jan; 508(4):1252-1258. PubMed ID: 30558790
[TBL] [Abstract][Full Text] [Related]
8. Seed oil of Rosa roxburghii Tratt against non-alcoholic fatty liver disease in vivo and in vitro through PPARα/PGC-1α-mediated mitochondrial oxidative metabolism.
Ni HY; Yu L; Zhao XL; Wang LT; Zhao CJ; Huang H; Zhu HL; Efferth T; Gu CB; Fu YJ
Phytomedicine; 2022 Apr; 98():153919. PubMed ID: 35104757
[TBL] [Abstract][Full Text] [Related]
9. Lycopene Prevents DEHP-Induced Liver Lipid Metabolism Disorder by Inhibiting the HIF-1α-Induced PPARα/PPARγ/FXR/LXR System.
Zhao Y; Ma DX; Wang HG; Li MZ; Talukder M; Wang HR; Li JL
J Agric Food Chem; 2020 Oct; 68(41):11468-11479. PubMed ID: 32962341
[TBL] [Abstract][Full Text] [Related]
10. [Effect of targeted inhibition of hypoxia-inducible factor-1α by 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole on the progression of non-alcoholic fatty liver disease in rats].
Shen WD; Zhang W; Xu QH; Liu PF
Zhonghua Gan Zang Bing Za Zhi; 2016 Oct; 24(10):749-754. PubMed ID: 27938560
[No Abstract] [Full Text] [Related]
11. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress.
Jiang Y; Chen L; Wang H; Narisi B; Chen B
J Ethnopharmacol; 2015 Dec; 176():499-507. PubMed ID: 26571089
[TBL] [Abstract][Full Text] [Related]
12. Gentiopicroside Ameliorates Oxidative Stress and Lipid Accumulation through Nuclear Factor Erythroid 2-Related Factor 2 Activation.
Jin M; Feng H; Wang Y; Yan S; Shen B; Li Z; Qin H; Wang Q; Li J; Liu G
Oxid Med Cell Longev; 2020; 2020():2940746. PubMed ID: 32655764
[TBL] [Abstract][Full Text] [Related]
13. Activation of peroxisome proliferator-activated receptor α (PPARα) suppresses hypoxia-inducible factor-1α (HIF-1α) signaling in cancer cells.
Zhou J; Zhang S; Xue J; Avery J; Wu J; Lind SE; Ding WQ
J Biol Chem; 2012 Oct; 287(42):35161-35169. PubMed ID: 22932900
[TBL] [Abstract][Full Text] [Related]
14. Danlou Tablet Improves Chronic Intermittent Hypoxia-Induced Dyslipidemia and Arteriosclerosis by HIF-1α-Angptl4 mRNA Signaling Pathway.
Tang JJ; Li GX; Liu ZG; Yi R; Yu D; Zhang YB; Zhao SQ; Wang SH
Chin J Integr Med; 2022 Jun; 28(6):509-517. PubMed ID: 32623702
[TBL] [Abstract][Full Text] [Related]
15. ACACA reduces lipid accumulation through dual regulation of lipid metabolism and mitochondrial function via AMPK- PPARα- CPT1A axis.
Dong J; Li M; Peng R; Zhang Y; Qiao Z; Sun N
J Transl Med; 2024 Feb; 22(1):196. PubMed ID: 38395901
[TBL] [Abstract][Full Text] [Related]
16. N-glycosylation of CREBH improves lipid metabolism and attenuates lipotoxicity in NAFLD by modulating PPARα and SCD-1.
Zhang N; Wang Y; Zhang J; Liu B; Deng X; Xin S; Xu K
FASEB J; 2020 Nov; 34(11):15338-15363. PubMed ID: 32996649
[TBL] [Abstract][Full Text] [Related]
17. Losartan Prevents Hepatic Steatosis and Macrophage Polarization by Inhibiting HIF-1α in a Murine Model of NAFLD.
Wang CH; Liu HM; Chang ZY; Huang TH; Lee TY
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360607
[TBL] [Abstract][Full Text] [Related]
18. Apigenin-induced HIF-1α inhibitory effect improves abnormal glucolipid metabolism in AngⅡ/hypoxia-stimulated or HIF-1α-overexpressed H9c2 cells.
Zhu ZY; Wang F; Jia CH; Xie ML
Phytomedicine; 2019 Sep; 62():152713. PubMed ID: 31078968
[TBL] [Abstract][Full Text] [Related]
19. Hepatic hypoxia-inducible factors inhibit PPARα expression to exacerbate acetaminophen induced oxidative stress and hepatotoxicity.
Li D; Du Y; Yuan X; Han X; Dong Z; Chen X; Wu H; Zhang J; Xu L; Han C; Zhang M; Xia Q
Free Radic Biol Med; 2017 Sep; 110():102-116. PubMed ID: 28583670
[TBL] [Abstract][Full Text] [Related]
20. Metformin Mitigates Nickel-Elicited Angiopoietin-Like Protein 4 Expression via HIF-1α for Lung Tumorigenesis.
Kang YT; Hsu WC; Ou CC; Tai HC; Hsu HT; Yeh KT; Ko JL
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
